High-quality mRNAs for robust and reproducible protein expression

At Tebubio, they understand that reproducibility, speed, and confidence in your reagents are critical to your research.

That is why they partner with TriLink BioTechnologies, a pioneer in RNA synthesis, to provide ready-to-use, high-performance premade mRNAs designed to accelerate your discovery programmes, from basic research to advanced therapeutic development.

Discover how CleanCap® technology improves mRNA performance

TriLink’s premade mRNAs are manufactured using proprietary CleanScript™ in vitro transcription (IVT) or the CleanCap® M6 co-transcriptional capping technology, significantly reducing double-stranded RNA (dsRNA) contaminants while maximising in vivo protein expression.

Manufactured for confidence, consistency and performance

All premade mRNAs are produced under strict quality standards and purified through DNase treatment, diafiltration, and oligo-dT capture. This process enriches full-length transcripts while efficiently removing impurities and salts.

Each product is delivered with a Certificate of Analysis (CoA) including:

  • Concentration determination by UV-Vis spectroscopy
  • Construct integrity assessed by gel and capillary electrophoresis
  • Capping efficiency measured by capping assay
  • dsRNA level quantified by dot blot

This ensures reliable performance and peace of mind when moving from optimisation to functional studies.

Quick selection guide: mRNA design options

TriLink offers premade mRNAs in three optimised designs: CleanCap® mRNAs, CleanCap® mRNAs (5moU), and CleanCap® M6 mRNAs (N1MeΨ).

All constructs include:

  • A 5′ Cap 1 structure for enhanced stability and translation
  • A synthetic 5′ UTR with a strong Kozak sequence
  • A mouse α-globin-derived 3′ UTR

Poly(A) tail optimisation

TriLink’s proprietary ModTail™ poly(A) tail modification increases mRNA stability, improves expression consistency, and extends the duration of protein expression—key advantages for next-generation RNA research.

How to choose the optimal design

  • ModTail™ → Improved stability and expression consistency
  • 5moU → Reduced innate immune activation with strong expression
  • N1MeΨ → Maximum protein expression with minimal immunogenicity
  • 5mC → Additional immune suppression and stability
  • CleanCap® AG → Robust expression for standard research applications
  • CleanCap® M6 → Highest expression levels with the lowest innate immune activation

1. Reporter mRNA

Used to monitor transfection efficiency, protein expression, and assay performance.

Product Description Reference
CleanCap® M6 EGFP mRNA / M6 EGFP ModTail™ mRNA (N1MeΨ) L-8101 / L-8101A
CleanCap® EGFP mRNA L-7601
CleanCap® M6 Firefly Luciferase (FLuc) mRNA / M6 FLuc ModTail™ mRNA (N1MeΨ) L-8102 / L-8102A
CleanCap® Firefly Luciferase (FLuc) mRNA L-7602
CleanCap® AU EGFP saRNA (5mC) L-7901
CleanCap® AU EGFP saRNA L-7801
CleanCap® AU Firefly Luciferase (FLuc) saRNA (5mC) L-7902
CleanCap® AU Firefly Luciferase (FLuc) saRNA L-7802
CleanCap® Renilla Luciferase mRNA (5moU) L-7204

2. Genome editing / functional protein mRNA

Encodes proteins for genome manipulation and targeted cellular functions.

Product Description Reference
CleanCap® M6 Cas9 mRNA / M6 Cas9 ModTail™ mRNA (N1MeΨ) L-8106 / L-8106A
CleanCap® Cas9 mRNA / Cas9 mRNA (5moU) L-7606 / L-7206
CleanCap® Cas9 Nickase mRNA (5moU) L-7207
CleanCap® M6 Cre mRNA (N1MeΨ) / Cre mRNA (5moU) L-8111 / L-7211

3. Gene replacement / therapeutic target mRNA

Used in phenotypic studies, pathway validation, and protein expression research.

Product Description Reference
CleanCap® M6 EPO mRNA (N1MeΨ) L-8109
CleanCap® EPO mRNA (5moU) L-7209
CleanCap® β-galactosidase mRNA / β-gal mRNA (5moU) L-7608 / L-7208

4. Antigen / immunology mRNA

For antigen presentation studies, immunological assays, and vaccine research.

Product Description Reference
CleanCap® Ovalbumin (OVA) mRNA L-7610
OVA mRNA (5moU) L-7210

5. Self-amplifying RNA (saRNA)

Self-replicating RNA constructs for enhanced and prolonged protein expression.

Product Description Reference
CleanCap® AU EGFP saRNA (5mC) L-7901
CleanCap® AU EGFP saRNA L-7801
CleanCap® AU Firefly Luciferase (FLuc) saRNA (5mC) L-7902
CleanCap® AU Firefly Luciferase (FLuc) saRNA L-7802

Custom mRNA Manufacturing

Our partner, TriLink, can manufacture our catalogue mRNA with other modified nucleotides and/or other capping technologies, within 2-3 weeks.

Ready to Advance Your Research?

Let our scientific team help you integrate the right RNA tools into your workflow.

Image: In HEK293T cells, eGFP mRNA, either modified with TriLink’s ModTail™ poly(A) tail or unmodified, was encoded and transfected using CleanCap® M6-capped mRNA. eGFP protein fluorescence was monitored over time using Incucyte®.

Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

GENESIS CEO Academy: Formación Estraté...

by GENESIS Biomed

GENESIS Biomed ha lanzado el programa GENESIS CEO Academy, una iniciat...

Photos Stream